6 min - BioSense Team - 2026-10-23
- level:understanding
- fsh ménopause
- taux fsh élevé
- œstradiol bas
- dosage hormonal ménopause
An FSH test cannot, on its own, tell you whether you have reached menopause after age 45. Menopause is defined by twelve months in a row without a period, and MedlinePlus (National Library of Medicine) notes that testing usually isn't needed at 45 or older. FSH levels fluctuate too much during the transition to settle the question with one result. The test keeps its value in specific cases, mainly before 45 and after a hysterectomy, set out below along with the tests that are useful at this stage of life.
Your periods have become further apart, you have hot flashes, and you would like to know where you stand. The request seems reasonable: a blood test or an at-home menopause test ought to be able to answer it.
It rarely can, because the biology of this period lends itself poorly to a one-off measurement.
How menopause is diagnosed: twelve months without a period
The definition has nothing to do with a lab value. You reach menopause after 12 months in a row with no period, including no spotting, according to the US Office on Women's Health.
The diagnosis is made after the fact. It is not made at the moment periods stop, but a year later. Nobody can tell you, on the day of your last period, that it was the last one.
The diagnosis is clinical. It rests on your history, your cycles and your symptoms, not on a number.
The transition into menopause usually happens between ages 45 and 55. The average age of natural menopause in the US is about 51 to 52, depending on the source: ACOG gives 51, the Office on Women's Health 52. Differences between individuals are wide.
Why FSH levels do not confirm menopause
FSH (follicle-stimulating hormone) is made by the pituitary gland to stimulate the ovaries, and it is measured with a simple blood test. When the ovaries respond less, the pituitary makes more of it. The reasoning therefore seems sound: a high FSH ought to confirm menopause.
The problem lies elsewhere. During the transition, this hormone does not rise steadily, it swings. The STRAW+10 staging criteria, the international reference for reproductive aging, describe FSH in the late transition as sometimes in the menopausal range and sometimes in the range of earlier reproductive years, with levels above 25 IU/L (25 mIU/mL) on a random draw being characteristic of that stage.
A test therefore captures a moment, not a trajectory. Two samples a couple of weeks apart can point to opposite conclusions.
That is why MedlinePlus says that testing usually isn't needed from age 45. In the UK, NICE goes further and says to identify perimenopause and menopause without lab tests in otherwise healthy people aged 45 or over who have symptoms.
What FSH level indicates menopause on a lab report?
Your report may print ranges by life stage. MedlinePlus gives, as examples, 4.7 to 21.5 mIU/mL (same number in IU/L) while still menstruating and 25.8 to 134.8 mIU/mL after menopause. These are lab ranges, not a diagnosis, and each lab publishes its own.
Does an estradiol test confirm menopause?
Same conclusion, for the same reason: estradiol also fluctuates widely in the transition. NICE lists estradiol among the tests not to use to identify menopause at 45 or over, along with anti-Müllerian hormone (AMH), which is often marketed for this purpose, and inhibins.
Key point - From age 45, menopause is identified from twelve months without a period and from symptoms. FSH and estradiol are usually not needed, because these hormones fluctuate too much during the transition for a one-off measurement to settle the question.
When is an FSH test useful?
FSH before 45: early menopause and premature ovarian insufficiency
When periods stop earlier than expected, the question changes. It is no longer about confirming an expected event, but about understanding why it is happening at this age. MedlinePlus lists premature menopause (age 40 or younger) and early menopause (before 45) among the medical reasons to test FSH, along with other hormones, and also symptoms whose cause isn't clear.
Before age 40, doctors speak of premature ovarian insufficiency (POI). Criteria differ between guidelines, and the difference is worth knowing:
- In the US, the National Institute of Child Health and Human Development (NICHD) describes missed or irregular periods for 4 months together with high FSH, and a doctor may do two FSH tests at least a month apart. ACOG also has a committee opinion on POI, reaffirmed in 2025.
- In the UK, NICE relies on symptoms and raised FSH on 2 samples taken 4 to 6 weeks apart.
- Internationally, the 2024 guideline from ESHRE, ASRM and other societies simplified this to a single FSH above 25 IU/L (25 mIU/mL), with a second test only if there is doubt.
In every case, a doctor makes the diagnosis. This situation warrants specialist care, with implications that go beyond symptoms.
FSH after a hysterectomy with the ovaries preserved
Periods can no longer serve as a marker once the uterus has been removed, while the ovaries keep working. The usual clinical marker disappears.
Here, a doctor relies mostly on symptoms and age, and may use repeated hormone tests when there is a medical reason. Values are read case by case, not against a single home-use cutoff.
FSH on birth control: a test usually not helpful
Combined birth control, progestin-only methods, an implant or a hormonal IUD can change or suppress periods. The clinical marker becomes unusable, and many people then ask for a test to find out where they stand.
NICE says not to use an FSH test to identify menopause in people on combined contraception or high-dose progestogen. The question of when to stop birth control is best settled in a conversation with your doctor or nurse practitioner. You can still become pregnant during perimenopause, so do not stop on the basis of a home test or a single lab value.
Menopause after cancer treatment
Chemotherapy can stop periods without settling whether menopause is permanent, and one blood test does not answer that. The usual definition may not apply in the same way, so this question belongs with your oncology team.
Key point - The test keeps its value before age 45, and where the absence of periods can no longer serve as a marker, notably after a hysterectomy. On birth control, FSH is usually not informative: discuss the next step with your doctor.
If hormone tests add little, other markers become more interesting to follow from age fifty onward. BioSense helps you understand each of them, set in the context of your personal situation, and follow their trend from one test to the next. Your data is hosted on servers located in France.
[→ Import my blood test](/en/onboarding/upload)
Which tests to follow after menopause?
The fall in estrogen comes with gradual metabolic changes, whether or not you feel any symptoms.
Cholesterol and lipid panel after menopause
An American Heart Association scientific statement (2020) describes the menopause transition as a time of accelerating cardiovascular risk, with adverse changes in body composition, lipids and lipoproteins. The USPSTF (2022) bases its statin recommendations for adults aged 40 to 75 on cardiovascular risk factors, which include abnormal cholesterol levels.
Fasting blood glucose after menopause
Body composition also shifts. The USPSTF (2021, grade B) recommends screening for prediabetes and type 2 diabetes in adults aged 35 to 70 who have overweight or obesity. Regular monitoring makes it possible to spot a gradual trend before a threshold is crossed.
Bone health: a DEXA scan rather than a blood test
ACOG notes that bone loss is faster in the first 4 to 8 years after menopause. The assessment does not rest on a blood test but on a bone density measurement. The USPSTF (January 2025, grade B) recommends osteoporosis screening for women aged 65 or older, and for postmenopausal women younger than 65 who have one or more risk factors.
TSH: telling a thyroid disorder from menopause
The symptoms of a thyroid disorder partly overlap with those of menopause: fatigue, weight change, mood changes. A TSH test can help tell the two apart when there is doubt.
These monitoring decisions are discussed with your doctor, according to your personal and family history.
The BioSense method
FSH seems to be the obvious answer to "am I in menopause?", and it is not: meanwhile, numbers that are genuinely changing often go unnoticed. BioSense sets each biomarker against what you tell us about your situation, then follows its trend from one test to the next.
*ChatGPT answers you. BioSense knows you.* *BioSense, your prevention companion.* BioSense does not provide a diagnosis and does not replace your doctor. It is a prevention companion that helps you understand, ask the right questions and act day to day.
FSH and menopause: three questions to ask your doctor
If you are wondering about your hormonal status, these three questions move the appointment toward what can genuinely help:
- Given my age, my cycles and my symptoms, would a hormone test add anything in my situation, or is observation enough?
- Which metabolic markers deserve to be followed from now on, and how often?
- Given my personal and family history, should I have a bone density test?
If you are on hormonal birth control, say so precisely. It changes the whole approach, as explained above.
Frequently asked questions
Can a blood test confirm menopause?
Usually not, and from age 45 a blood test usually isn't needed. Menopause is defined as twelve months in a row without a period. An FSH or estradiol level measured on a given day does not change that definition.
What FSH level indicates menopause?
No FSH level on its own establishes menopause after 45. Lab reports often show a postmenopausal range starting around 25 mIU/mL (25 IU/L), and FSH above 25 IU/L is characteristic of the late transition in STRAW+10. Because FSH swings, these values are read with a doctor.
When is an FSH test done in women?
An FSH test is mainly discussed before age 45, when periods change or stop earlier than expected, or when the cause of symptoms isn't clear. It can also help after a hysterectomy, when periods no longer serve as a marker. Your doctor decides whether to order it.
Is FSH reliable on birth control?
No, FSH is not a useful marker on combined hormonal birth control. NICE, in the UK, says so for combined contraception and high-dose progestogens. The question is better settled by discussing your options with your doctor.
Are at-home menopause tests accurate?
They can detect FSH, but they cannot tell you whether you have reached menopause. FSH swings during the transition, so one result captures a single moment. A positive or negative result does not replace a conversation with your doctor, and it does not tell you it is safe to stop birth control.
*This article is strictly informational and constitutes neither medical advice nor a diagnosis. For any question about your health, consult your doctor.*
Import your blood tests and receive a plain-language reading of each of your biomarkers, set in the context of your personal situation and followed over time. Over a period when changes settle in gradually, it is the trend that is most informative. Your data is hosted on servers located in France.
[→ Import my blood tests](/en/onboarding/upload)
Sources and methodology
International
- Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10 (STRAW+10). Menopause, 2012;19(4):387-395. PMC
- ESHRE, ASRM, CREWHIRL and IMS Guideline Group on POI. Evidence-based guideline: premature ovarian insufficiency. Human Reproduction Open, 2024;2024(4):hoae065. ESHRE
United States
- MedlinePlus, National Library of Medicine. Follicle-Stimulating Hormone (FSH) Levels Test. MedlinePlus
- MedlinePlus, National Library of Medicine. Follicle-stimulating hormone (FSH) blood test. MedlinePlus
- Office on Women's Health, US Department of Health and Human Services. Menopause basics. womenshealth.gov
- American College of Obstetricians and Gynecologists. The Menopause Years. Last reviewed December 2025. ACOG
- American College of Obstetricians and Gynecologists. Primary Ovarian Insufficiency in Adolescents and Young Women. Committee Opinion, 2014, reaffirmed 2025. ACOG
- NICHD, National Institutes of Health. How do healthcare providers diagnose POI? NICHD
- The Menopause Society. Position statements, including The 2022 Hormone Therapy Position Statement. The Menopause Society
- El Khoudary SR, et al. Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention. American Heart Association scientific statement. Circulation, 2020;142(25):e506-e532. PubMed
- US Preventive Services Task Force. Osteoporosis to Prevent Fractures: Screening. 2025. USPSTF
- US Preventive Services Task Force. Prediabetes and Type 2 Diabetes: Screening. 2021. USPSTF
- US Preventive Services Task Force. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults. 2022. USPSTF
United Kingdom
- National Institute for Health and Care Excellence. Menopause: identification and management. NICE guideline NG23, 2015, last updated April 2026. NICE
*Methodology note: this article does not address menopausal hormone therapy, whose benefits and risks are a matter for an individual discussion with a doctor. The Menopause Society's 2022 position statement remains its reference statement on the subject.*
*BioSense methodology: our content is based on guidance from US authorities and medical societies (such as the USPSTF, CDC, NIH, FDA, ACC/AHA and ADA), UK bodies (NICE, NHS), European societies and the WHO. Sources are listed by country, and differences between countries are stated when they matter.*